Skip to main content
. 2013 Jun 19;18(2):130–140. doi: 10.1111/jns5.12017

Figure 1.

Figure 1

Patient disposition. Of 31 screened patients, 28 were enrolled into the study and received the induction Privigen® dose. A total of three patients discontinued during the induction and maintenance phases, leaving 25 patients who completed the study.